Regulus Therapeutics (RGLS)

1.42 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/31/18 *Est.)

Latest Headlines

Regulus Therapeutics (RGLS) enters $20 million 'at-the-market' equity offering via H.C.Wainwright December 12, 2018 5:04 PM - StreetInsider Form 8-K Regulus Therapeutics For: Dec 12 December 12, 2018 4:57 PM - SEC Filing Form 424B5 Regulus Therapeutics December 12, 2018 4:52 PM - SEC Filing Form SC 13G/A Regulus Therapeutics Filed by: FMR LLC December 10, 2018 9:03 AM - SEC Filing Form 4 Regulus Therapeutics For: Nov 12 Filed by: PAPADOPOULOS STELIOS November 21, 2018 5:31 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 15 Filed by: PAPADOPOULOS STELIOS November 19, 2018 4:04 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 16 Filed by: Collier Kathryn J November 19, 2018 4:03 PM - SEC Filing Regulus Presents Preclinical Survival Data Highlighting Potential of Novel Treatment for Glioblastoma Multiforme November 19, 2018 8:00 AM - PR NewsWire Form 8-K Regulus Therapeutics For: Nov 13 November 16, 2018 4:17 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 12 Filed by: BALTIMORE DAVID November 13, 2018 5:36 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 12 Filed by: Collier Kathryn J November 13, 2018 5:35 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 12 Filed by: RASTETTER WILLIAM H November 13, 2018 5:35 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 12 Filed by: Rosen Hugh November 13, 2018 5:34 PM - SEC Filing Form 4 Regulus Therapeutics For: Nov 12 Filed by: Witz Pascale November 13, 2018 5:33 PM - SEC Filing Form SC TO-I/A Regulus Therapeutics Filed by: Regulus Therapeutics Inc. November 13, 2018 4:09 PM - SEC Filing Form SC TO-I/A Regulus Therapeutics Filed by: Regulus Therapeutics Inc. November 13, 2018 6:05 AM - SEC Filing Form SC TO-I/A Regulus Therapeutics Filed by: Regulus Therapeutics Inc. November 9, 2018 4:35 PM - SEC Filing Form 10-Q Regulus Therapeutics For: Sep 30 November 9, 2018 6:21 AM - SEC Filing Form 8-K Regulus Therapeutics For: Nov 08 November 8, 2018 4:19 PM - SEC Filing Regulus Reports Third Quarter 2018 Financial Results and Recent Updates November 8, 2018 4:05 PM - PR NewsWire Regulus Therapeutics (RGLS) Announces Restructuring of Sanofi (SNY) Collaboration November 6, 2018 7:40 AM - StreetInsider Regulus Announces Successful Restructuring of Sanofi Collaboration November 6, 2018 7:30 AM - PR NewsWire Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018 October 25, 2018 4:05 PM - PR NewsWire Form CT ORDER Regulus Therapeutics October 23, 2018 11:04 AM - SEC Filing Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018 October 22, 2018 4:05 PM - PR NewsWire Regulus Therapeutics (RGLS) Regains Compliance with NASDAQ Listing Requirements October 18, 2018 4:38 PM - StreetInsider Regulus Regains Compliance with NASDAQ Listing Requirements October 18, 2018 4:05 PM - PR NewsWire Form SC TO-I Regulus Therapeutics Filed by: Regulus Therapeutics Inc. October 15, 2018 5:26 PM - SEC Filing Regulus Therapeutics (RGLS) Reports 1-for-12 Reverse Share Split October 4, 2018 8:06 AM - StreetInsider Regulus Therapeutics Announces Reverse Stock Split October 4, 2018 8:05 AM - PR NewsWire Form 8-K Regulus Therapeutics For: Sep 28 October 2, 2018 5:18 PM - SEC Filing Regulus to Participate in Fireside Chat at the Chardan Genetic Medicines Conference October 2, 2018 4:05 PM - PR NewsWire Exicure Presents First Data Demonstrating Both Oral Delivery and Liver Delivery of Spherical Nucleic Acid Constructs in Animal Models October 2, 2018 7:00 AM - BizWire Regulus to Present at the Cantor Fitzgerald Global Healthcare Conference September 27, 2018 4:05 PM - PR NewsWire Regulus Therapeutics (RGLS) Announces Update on Advancements to Pipeline Programs September 26, 2018 4:09 PM - StreetInsider Regulus Provides Pipeline Updates September 26, 2018 4:05 PM - PR NewsWire Form CT ORDER Regulus Therapeutics September 19, 2018 5:03 PM - SEC Filing Full Article List